AU2002350432A1 - Combination of cimetidine and cysteine derivatives for treating cancer - Google Patents

Combination of cimetidine and cysteine derivatives for treating cancer

Info

Publication number
AU2002350432A1
AU2002350432A1 AU2002350432A AU2002350432A AU2002350432A1 AU 2002350432 A1 AU2002350432 A1 AU 2002350432A1 AU 2002350432 A AU2002350432 A AU 2002350432A AU 2002350432 A AU2002350432 A AU 2002350432A AU 2002350432 A1 AU2002350432 A1 AU 2002350432A1
Authority
AU
Australia
Prior art keywords
cimetidine
combination
treating cancer
cysteine derivatives
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002350432A
Other versions
AU2002350432A8 (en
Inventor
Morten Sloth Weidner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTION ONCOLOGY APS
Original Assignee
ASTION ONCOLOGY APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTION ONCOLOGY APS filed Critical ASTION ONCOLOGY APS
Publication of AU2002350432A8 publication Critical patent/AU2002350432A8/en
Publication of AU2002350432A1 publication Critical patent/AU2002350432A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002350432A 2001-11-26 2002-11-26 Combination of cimetidine and cysteine derivatives for treating cancer Abandoned AU2002350432A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA200101761 2001-11-26
DKPA200101761 2001-11-26
DKPA200201086 2002-07-10
DKPA200201086 2002-07-10
US39534402P 2002-07-12 2002-07-12
US60/395,344 2002-07-12
PCT/DK2002/000792 WO2003045359A2 (en) 2001-11-26 2002-11-26 Combination of cimetidine and cysteine derivatives for treating cancer

Publications (2)

Publication Number Publication Date
AU2002350432A8 AU2002350432A8 (en) 2003-06-10
AU2002350432A1 true AU2002350432A1 (en) 2003-06-10

Family

ID=27222564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002350432A Abandoned AU2002350432A1 (en) 2001-11-26 2002-11-26 Combination of cimetidine and cysteine derivatives for treating cancer

Country Status (2)

Country Link
AU (1) AU2002350432A1 (en)
WO (1) WO2003045359A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10337638A1 (en) * 2003-08-16 2005-03-24 Kirschfeld, Kuno, Prof. Dr. Method of treating prostatitis
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
US8173809B2 (en) 2008-02-07 2012-05-08 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
FR2709960B1 (en) * 1993-09-14 1995-12-01 Marthe Dehorne Use of a composition for the preparation of a medicament intended to maintain or restore a rate of aggregation of blood platelets close to the normal value.
DE10004651A1 (en) * 2000-02-03 2001-08-16 Jutta Dierkes Combination of antihypertensive agents with drugs that reduce homocysteine levels
WO2001074780A1 (en) * 2000-03-21 2001-10-11 Astion Development Aps Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
US20020137785A1 (en) * 2001-03-26 2002-09-26 George Kindness Inflammatory mechanism modulator composition and methods with anti-asthmatic properties

Also Published As

Publication number Publication date
AU2002350432A8 (en) 2003-06-10
WO2003045359A3 (en) 2003-12-18
WO2003045359B1 (en) 2004-02-19
WO2003045359A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002258399A1 (en) Use of trail and antiprogestins for treating cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU2002363005A1 (en) Derivatives of uk-2a
AU2002307217A1 (en) Materials and methods for treatment of cancer and identification of anti-cancer compounds
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002252456A1 (en) Combination treatment of pancreatic cancer
AU2002252227A1 (en) Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
EP1176964B8 (en) Uses of et743 for treating cancer
AU2002367172A1 (en) 2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
IL145397A0 (en) Compositions and methods for treatment of cancer
AU2002304785A1 (en) Use of cysteine protease-inhibitors for treating illnesses
PL368035A1 (en) Compositions and methods for the treatment of cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU2002350432A1 (en) Combination of cimetidine and cysteine derivatives for treating cancer
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002305823A1 (en) Cancer treatment method and compositions comprising compounds of the ginger family
AU2001249493A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AUPR644301A0 (en) Method and composition for treatment of cancer
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2002306952A1 (en) Detection and treatment of colorectal cancer
AU2002305138A1 (en) Methods and materials for cancer treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase